PF-Atlas › Clinical Trials › NCT04535245

Lung Clearance Index to Identify Scleroderma Patients at Risk for ILD

LCI testing · Not specified

Registry ID

NCT04535245

Phase

Not specified

Status

Unknown

Drug / intervention

LCI testing

Sponsor

National Jewish Health

Start

2021-01-04

About this trial

LCI testing is evaluated in NCT04535245, a idiopathic pulmonary fibrosis study sponsored by National Jewish Health. Current status: Unknown.

View NCT04535245 on ClinicalTrials.gov →

Explore related

All LCI testing trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT04535245 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.